*  Healthcare | Free Full-Text | Antifungal Effect of Non-Woven Textiles Containing Polyhexamethylene Biguanide with Sophorolipid:...
... and efficacy of non-woven textiles containing polyhexamethylene biguanide (PHMB) mixed with sophorolipid. Permeability of PHMB ... Antifungal Effect of Non-Woven Textiles Containing Polyhexamethylene Biguanide with Sophorolipid: A Potential Method for Tinea ... "Antifungal Effect of Non-Woven Textiles Containing Polyhexamethylene Biguanide with Sophorolipid: A Potential Method for Tinea ... and efficacy of non-woven textiles containing polyhexamethylene biguanide (PHMB) mixed with sophorolipid. Permeability of PHMB ...
*  ADA's 2014 Standards of Care Released
The American Diabetes Association has released their annually revised Standards of Medical Care in Diabetes for 2014, with an emphasis on individualized
*  Aaron I. Vinik, MD, PhD, FCP, MACP, Author at Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals.
Advisory Board Member) Dr. Vinik has brought international recognition to Virginia as a result of his research and recent discovery of a gene, which could prove to be a cure for diabetes. The gene, INGAP (islet neogenesis associated protein) is responsible, either alone or in combination with other factors, for stimulating immature cells in the diabetic pancreas to produce insulin. When INGAP protein was administered to diabetic hamsters it was shown to reverse diabetes in 40% to 50% of animals. Animal studies were followed by human, multi-center clinical studies in both type 1 and type 2 diabetes, carried out by some of the most highly recognized investigators in the country; the results showed that even in type 1 diabetes an increase in C- peptide, (a measure of islet function), could be induced after 3 months of treatment ...
*  New Study Demonstrates Low-Carb Diets Reduce Risk for Heart Disease and Inflammation
When overweight or obese people lose weight, using a low carb diet, they can have a significant reduction in inflammation throughout their body, as
*  Cardiology Opportunity......80 miles from Salt Lake City
Pro-Med Resources INTL Inc. Location : Evanston WY US Cardiology Opportunity......minutes from Salt Lake CityRocky Mountian community 80 mi east of Salt
*  Products - Diabetes In Control
Tandem Diabetes Care has released its long awaited t:slim Insulin Delivery System, a 300 unit insulin pump that looks like it was designed by Apple. The face of the t:slim is the size of a credit card and all functions are controlled through its beautiful touch screen. It's recharged using a …. Read More » ...
*  Statin Therapy for Diabetics May Prevent Alzheimer's
A new study suggests that taking statins is associated with a 39% reduction in risk of developing Alzheimer's disease. A team of Boston University epidemio
*  BG Levels during Acute Illness Can Help Predict Future Diabetes Risk
Blood glucose levels measured in hospitalized patients during acute illness predicted the risk of developing type 2 diabetes in the following three
*  Steve Freed, R.PH., CDE, Author at Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. - Page 14...
Publisher Diabetes In Control) Stephen Freed, a registered pharmacist and diabetes educator, is the founder and publisher of Diabetes In Control. He is dedicated to advancing diabetes care for patients, physicians, pharmacists, and nurses. Steve has worked with many physicians helping them manage their diabetes patients. He has been president of the Chicago Chapter of the American Association of Diabetes Educators, is a certified pump trainer, and has developed and presented CE/CME programs for AADE.. ...
*  Products - Diabetes In Control
Dexcom is creating an app for the soon-to-be-released Apple Watch to receive and display data from its glucose monitors using their Share technology. The smartwatch, which is due out in April, will display readings as an easy-to-read graph. Dexcom has already created apps for iOS devices including the Follow …. Read More » ...
*  Remote Wireless Monitoring Can Help Patients Newly Diagnosed with T1
A patient of mine was newly diagnosed with type 1 diabetes. He started on insulin and I taught him about glucose targets; insulin administration,
*  Type 1 Diabetes Prevention with Early Insulin a Bust
Insulin therapy doesn't prevent type 1 diabetes in genetically high-risk infants showing early signs of the autoimmune disease, researchers found. In children with elevated genetic risk, nasal insulin started soon after detection of diabetes-associated autoantibodies had no effect on development of type 1 diabetes,
*  Current Interview: Francine Kaufman
Dr. Francine Kaufman was named Chief Medical Officer and Vice President of Global Medical, Clinical and Health Affairs in April 2009.
*  Editor's Note, DCMS #229
This week's Clinical Mastery Series newsletter is chock full of great information to help with your patients. First we wrap up our killer Homerun Slides series on DME. Next up is Part 1 of the latest in insulin management techniques from Practical Diabetes Care. Our Disaster Averted works quite well with the
*  Medical Assistant
Arizona Oncology Associates Location : Phoenix AZ US Performs clinic support tasks including miscellaneous clerical tasks, answeringphones, and maintaining physician's schedule.... More || jobs
*  Reduced Physical Activity in Adults with Prediabetes Puts Them at Risk
In study of reduced physical activity in adults with prediabetes, just two weeks of inactivity caused impaired glycemic control; may progress to type 2.
*  Specialties - Diabetes In Control
Youths who received any breastfeeding for at least 12 months or full breastfeeding for at least six months had lower odds of developing type 1 diabetes.. Read More » ...
*  Test Your Knowledge - Diabetes In Control
Mr. Carlson is a 52-year-old Caucasian grocery store manager you saw last week for a new patient visit. His labs from that visit were significant for elevated random plasma glucose 166 mg/dL, A1C 7.4% and elevated lipids (TG=175 mg/dL, LDL 148 mg/dL, HDL 38 mg/dL, total cholesterol 221 mg/dL). He has returned to your clinic for a follow-up appointment. His physical exam is notable for central abdominal obesity (waist circumference 42"), left eyelid xanthelasma, BP 147/91, HR 72, RR 18, BMI 36 kg/m2, but otherwise normal. A repeat A1C test shows A1C 7.6%. Mr. Carlson smokes between 1 and 1.5 packs of cigarettes daily. After discussing the labs and your findings with Mr. Carlson, you begin collaborating on a management plan. You write prescriptions for metformin, a statin and ACE inhibitor. Mr. Carlson doesn't think "taking medication will be too tough," but expresses skepticism about your recommendations for a change in his diet, exercise and smoking programs because he has tried them, without ...
*  Calcium Concentration Tied to Diabetes
According to an Insulin Resistance Atherosclerosis Study (IRAS), high calcium serum concentrations are associated with an increased risk for type 2 diabete
*  Apple Cider Vinegar Diabetes Benefits: Apple Cider Vinegar and Type 1 Diabetes
Apple cider vinegar diabetes studies have shown that vinegar can improve insulin sensitivity; a Diabetes Care study looked at vinegar & type 1 diabetes.
*  New Targets in Preventing End-Stage Renal Disease and Death of Diabetes Patients
Patients with both Type 1 diabetes and CKD have an increased risk of adverse outcomes.... Despite aggressive treatment, many patients with Type 1 diabetes
*  Garmin Vivofit
... The Heart Rate Watch Company rated this the best of show for CES 2014. Unlike bands that have to be recharged every few days, it uses
*  Aaron Kowalski on JDRF and the Cause of Curing Type 1 Diabetes
Aaron Kowalski discusses JDRF and the work to advance the cause of curing type 1 diabetes & improve the quality of life for diabetes patients today.
*  Glucose Variability Affects Hemoglobin A1c
At any given average glucose level, high variability results in higher glycosylated hemoglobin level. In a study involving 427 diabetic patients (63% had t
*  No Higher Risk of Heart Failure with DPP-4 Inhibitors
... , study finds: saxagliptin or sitagliptin had similar risks as other anti-hyperglycemic agents.